Suppr超能文献

相似文献

2
Bone morphogenic protein 2 activates protein kinase D to regulate histone deacetylase 7 localization and repression of Runx2.
J Biol Chem. 2009 Jan 23;284(4):2225-34. doi: 10.1074/jbc.M800586200. Epub 2008 Nov 21.
3
Runx2 (Cbfa1, AML-3) interacts with histone deacetylase 6 and represses the p21(CIP1/WAF1) promoter.
Mol Cell Biol. 2002 Nov;22(22):7982-92. doi: 10.1128/MCB.22.22.7982-7992.2002.
5
Histone deacetylase 3 interacts with runx2 to repress the osteocalcin promoter and regulate osteoblast differentiation.
J Biol Chem. 2004 Oct 1;279(40):41998-2007. doi: 10.1074/jbc.M403702200. Epub 2004 Aug 2.
6
HDAC3 and HDAC7 have opposite effects on osteoclast differentiation.
J Biol Chem. 2011 Apr 8;286(14):12056-65. doi: 10.1074/jbc.M110.216853. Epub 2011 Feb 15.
7
p68 (Ddx5) interacts with Runx2 and regulates osteoblast differentiation.
J Cell Biochem. 2008 Apr 1;103(5):1438-51. doi: 10.1002/jcb.21526.
8
Zfp521 controls bone mass by HDAC3-dependent attenuation of Runx2 activity.
J Cell Biol. 2010 Dec 27;191(7):1271-83. doi: 10.1083/jcb.201009107. Epub 2010 Dec 20.
10
Foxo1 mediates insulin-like growth factor 1 (IGF1)/insulin regulation of osteocalcin expression by antagonizing Runx2 in osteoblasts.
J Biol Chem. 2011 May 27;286(21):19149-58. doi: 10.1074/jbc.M110.197905. Epub 2011 Apr 6.

引用本文的文献

1
Epigenetic Regulation of Bone Healing: Implications for Fracture Repair and Clinical Treatment Strategies.
Yale J Biol Med. 2025 Jun 30;98(2):159-170. doi: 10.59249/HSYL8000. eCollection 2025 Jun.
2
Landscape of Histone Posttranslational Modifications in Osteoarthritis.
J Inflamm Res. 2025 Jun 17;18:7893-7906. doi: 10.2147/JIR.S514599. eCollection 2025.
4
Scaffolding Activities of Pseudodeacetylase HDAC7.
ACS Chem Biol. 2025 Feb 21;20(2):248-258. doi: 10.1021/acschembio.4c00753. Epub 2025 Feb 5.
6
Unlocking the Epigenetic Symphony: Histone Acetylation Orchestration in Bone Remodeling and Diseases.
Stem Cell Rev Rep. 2025 Feb;21(2):291-303. doi: 10.1007/s12015-024-10807-2. Epub 2024 Nov 4.
7
Effects of EZH2 inhibitor, trichostatin A, and 5-azacytidine combinatorial treatment on osteogenic differentiation of dental pulp stem cells.
Heliyon. 2024 Jun 8;10(12):e32553. doi: 10.1016/j.heliyon.2024.e32553. eCollection 2024 Jun 30.
9
Role of miRNA-regulated type H vessel formation in osteoporosis.
Front Endocrinol (Lausanne). 2024 May 31;15:1394785. doi: 10.3389/fendo.2024.1394785. eCollection 2024.
10
Deacetylation of FOXP1 by HDAC7 potentiates self-renewal of mesenchymal stem cells.
Stem Cell Res Ther. 2023 Jul 28;14(1):188. doi: 10.1186/s13287-023-03376-7.

本文引用的文献

1
Inhibition of histone acetylation as a tool in bone tissue engineering.
Tissue Eng. 2006 Oct;12(10):2927-37. doi: 10.1089/ten.2006.12.2927.
2
Histone deacetylase 7 maintains vascular integrity by repressing matrix metalloproteinase 10.
Cell. 2006 Jul 28;126(2):321-34. doi: 10.1016/j.cell.2006.05.040.
3
Histone deacetylase 1-mediated histone modification regulates osteoblast differentiation.
Mol Endocrinol. 2006 Oct;20(10):2432-43. doi: 10.1210/me.2006-0061. Epub 2006 May 25.
4
Bone morphogenetic protein-2 stimulates Runx2 acetylation.
J Biol Chem. 2006 Jun 16;281(24):16502-11. doi: 10.1074/jbc.M512494200. Epub 2006 Apr 13.
6
Histone deacetylase inhibitors promote osteoblast maturation.
J Bone Miner Res. 2005 Dec;20(12):2254-63. doi: 10.1359/JBMR.050813. Epub 2005 Aug 8.
8
Class II histone deacetylases: from sequence to function, regulation, and clinical implication.
Mol Cell Biol. 2005 Apr;25(8):2873-84. doi: 10.1128/MCB.25.8.2873-2884.2005.
10
Impaired intranuclear trafficking of Runx2 (AML3/CBFA1) transcription factors in breast cancer cells inhibits osteolysis in vivo.
Proc Natl Acad Sci U S A. 2005 Feb 1;102(5):1454-9. doi: 10.1073/pnas.0409121102. Epub 2005 Jan 21.

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验